Skip to main content

Cibus, Inc. (CBUS) Stock Forecast

Data as of Aug 8, 2026

Healthcare · Current price $1.80 (-3.48%)

Consensus Target
$11.50
Upside
+537.1%
Analysts
1
Rating
Hold(3.00)

Price Target Range

Low $10.50Consensus $11.50High $12.50
▲ Current $1.80

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

CBUS vs Sector & Market

MetricCBUSHealthcare AvgLarge Cap Avg
Analyst Rating3.002.252.42
Analyst Count1818
Target Upside+537.1%+16285.8%+14.7%
P/E Ratio-5.113.5936.06

Revenue Estimates

PeriodLowAvgHigh#
2026-09-30$2M$2M$2M1
2026-12-31$2M$2M$3M1
2027-03-31$3M$3M$3M1
2027-06-30$3M$3M$4M1
2027-09-30$4M$4M$5M1
2027-12-31$4M$5M$6M1
2028-12-31$35M$42M$49M2
2029-12-31$134M$159M$186M1
2030-12-31$333M$396M$464M1

EPS Estimates

PeriodLowAvgHigh#
2026-09-30$-0.25$-0.20$-0.171
2026-12-31$-0.24$-0.20$-0.171
2027-03-31$-0.26$-0.21$-0.181
2027-06-30$-0.27$-0.22$-0.191
2027-09-30$-0.27$-0.22$-0.191
2027-12-31$-0.28$-0.23$-0.191
2028-12-31$-1.21$-0.82$-0.442
2029-12-31$0.25$0.31$0.381
2030-12-31$1.68$2.12$2.591

Frequently Asked Questions

What is the analyst consensus for CBUS?

The consensus among 1 analysts covering Cibus, Inc. (CBUS) is Hold with an average price target of $11.50.

What is the highest price target for CBUS?

The highest analyst price target for CBUS is $12.50.

What is the lowest price target for CBUS?

The lowest analyst price target for CBUS is $10.50.

How many analysts cover CBUS?

1 analysts have issued ratings for Cibus, Inc. in the past 12 months.

Is CBUS a buy or sell right now?

Based on 1 analyst ratings, CBUS has a consensus rating of Hold (3.00/5) with a +537.1% upside to the consensus target of $11.50.

What are the earnings estimates for CBUS?

Analysts estimate CBUS will report EPS of $-0.20 for the period ending 2026-09-30, with revenue estimated at $2M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.